Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
about
Medical therapy of acromegalySurgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis.Dynamic tests and basal values for defining active acromegaly.Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?What is active acromegaly and which parameters do we have?Management options for persistent postoperative acromegaly.Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.Biochemical investigations in diagnosis and follow up of acromegaly.Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly.Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.Nationwide survey of acromegaly in South Korea.Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study.How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.
P2860
Q35895856-B4A7A970-1346-4BD0-97E1-0DD9AAD3C97EQ36120577-39DD287E-6FEC-4700-9B18-0F5DFE0B0058Q36626485-EB53267E-8738-4707-856B-090A5FFA8A27Q36845980-C146C0C4-7800-49FD-AF19-2F3489A1F30FQ37977989-0DFB67F2-75DD-42BB-9879-D6DA63B7A4C9Q38049832-85E913C8-84D3-4FAF-8273-1865CC0CAD79Q38062441-CB10153F-7941-493F-B148-F1BCBAE52667Q38185306-9877756A-F736-4D88-8D54-27B09B999EE9Q38862772-B3F28698-958B-42D7-9AE0-8C29C72EB350Q39123579-8A198E21-B4C9-4E4C-A581-86FE1F5AEE98Q45926857-98E510BB-6AC3-4A11-B58C-F8377B7A712CQ45960408-6F1D1C2F-87D4-4CD8-A91D-662A41E2D9B7Q50944176-FE4A4E1D-8602-4FB6-BCAB-E8103A360684Q51191017-1A9AC2DD-C79C-4F3A-8B62-C4FF52430D84Q51750907-060CFD7D-49F0-444B-AA88-D34E4D386413Q54939988-49AFD535-CAE7-407C-88DF-50CB31FA9CCF
P2860
Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
type
label
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
prefLabel
Postoperative evaluation of pa ...... ormone-binding protein levels.
@en
Postoperative evaluation of pa ...... ormone-binding protein levels.
@nl
P2093
P356
P1476
Postoperative evaluation of pa ...... hormone-binding protein levels
@en
P2093
Bidlingmaier M
Feelders RA
Hofland LJ
Lamberts SW
Strasburger CJ
Uitterlinden P
de Herder WW
van der Lely AJ
P304
P356
10.1210/JC.2005-0901
P407
P577
2005-09-13T00:00:00Z